BHW Icon 2.3.jpg
DSC02436.JPG

About us

Combining science and strategy, BioHealthWays is your intellectual property advisor and research service in the health & life sciences, industrial products & manufacturing, consumer products, and specialty chemicals and biomaterials verticals.

Our Offering

We offer timely and high quality strategic and scientific expertise to support mission critical product growth, defense, and monetization


  • Intellectual Property search, assessment, drafting, and litigation support services

  • Research & Development, Manufacturing, and Supply Chain strategy & organization consulting

  • M&A valuable patent identification and portfolio quality analysis

 
DSC00907.JPG
 

Learn More

 

Experience across thousands of headlining cases. Mission-critical support for academic institutions and corporations throughout the research and development, product planning, and product lifecycle.

 
BHW Icon 2.3.jpg
 
 

CONTACT US

 

Please include in your inquiry the topic: new engagement, talent recruitment, investor relations, or service provider

Inquiry type *
Please select your inquiry reason
 
David Headshot.png

Meet david Pan, President, Chief Science Officer

David is co-founder, President, and Chief Technology/Business Officer  of BioHealthWays, Inc. David brings a unique combination of corporate commercialization and innovation as well as patent expertise. Having served at Xerox Corporation for over 32 years in various senior roles at the Office of General Counsel as well as Offices of Corporate Innovation and Research & Development, David has nearly 100 patents to his name, several of which have been commercialized and/or out-licensed.  Products utilizing his technology include: e-ink as used in the Kindle reader, various technologies in Xerox printers, and biomaterials in biomedical imaging. Through his innovations, he has delivered over $100M+ in customer value. David is an expert in product delivery of hydrogels, polymers, block copolymers, elastomer nano-composites, polymer chemistry, physics, engineering, and structure-property relationships. He has unusual expertise as an inventor and patents infringement investigator, and is called as an expert witness for general IP defense expertise in U.S. court investigations.

David is a member of various professional societies, including American Chemical Society, American Physical Society, and Materials Research Society. He has received numerous corporate awards and session chairmanships. He has written over 25 journal-accepted publications, and given multiple public talks at research organizations, professional societies, and conferences worldwide.

Research Interests:

  • Hydrogels, Polymers, Block Copolymers, polymer chemistry
  • Elastomer nano-composites
  • Physics, Engineering, Structure-property relationships

Education:

Ph.D. Chemical Engineering, University of Wisconsin-Madison

B.Eng. Chemical Engineering, National Taiwan University

 

OUr team

 


AK8A6018 square.jpg

Meet Brian Pan, CEo

Brian is the cofounder and CEO of BioHealthWays. Prior to BioHealthWays, Brian was a strategic advisor at Galt & Company, a firm that delivers high value strategies and implements operating conditions, to exceed customer and shareholder expectations. He has supported notable divestitures, acquisitions, and resource allocation strategies across corporate functional areas. Before Galt & Company, Brian worked at Accenture Strategy. Fortune 500 clients include: Coca-Cola, Caterpillar, Abbott Medical Optics, Bristol Myers Squibb, Fiat-Chrysler Automobiles, AT&T, Pitney Bowes.

Selected Cases:

Secondments:
Johannesburg, South Africa (12 months), Dubai, UAE (4 months), Jeddah, Saudi Arabia (4 months), Geneva, Switzerland (4 months), Istanbul, Turkey (12 months), Various intermittent locations Domestic and Global

Memberships:

Board, Columbia Engineering Young Alumni

Education:

B.S. IEOR: Engineering and Management Systems, Economics, Technical Entrepreneurship, Columbia University Fu Foundation School of Engineering and Applied Science with selected studies at Columbia Business School (MBA)

 

our Scientific and Business Advisors